Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HRD 100 Gene Expression High|Triple Negative Breast Cancer
Interventions: DRUG: Talazoparib
Sponsor: University of Malaya
Collaborators: Cancer Research Malaysia|Pfizer|Pantai Hospital Kuala Lumpur|Hospital Sultan Ismail